Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Isolated central nervous system relapse after nine years of complete molecular remission in a lymphoid blast crisis of chronic myeloid leukemia treated with imatinib.
Breccia M, Santopietro M, Cannella L, Federico V, Loglisci G, Serrao A, Petrucci L, Salaroli A, Nanni M, De Propris MS, Diverio D, Alimena G. Breccia M, et al. Among authors: serrao a. Leuk Res. 2011 Jun;35(6):e91-2. doi: 10.1016/j.leukres.2011.01.026. Epub 2011 Feb 11. Leuk Res. 2011. PMID: 21316103 No abstract available.
Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinib.
Loglisci G, Breccia M, Nanni M, Mancini M, De Cuia R, Cannella L, Salaroli A, Federico V, Serrao A, Loglisci MG, Santopietro M, Alimena G. Loglisci G, et al. Among authors: serrao a. Leuk Lymphoma. 2011 Jul;52(7):1372-5. doi: 10.3109/10428194.2011.565394. Epub 2011 Apr 4. Leuk Lymphoma. 2011. PMID: 21463110 No abstract available.
Low incidence rate of opportunistic and viral infections during imatinib treatment in chronic myeloid leukemia patients in early and late chronic phase.
Breccia M, Girmenia C, Latagliata R, Loglisci G, Santopietro M, Federico V, Petrucci L, Serrao A, Salaroli A, Alimena G. Breccia M, et al. Among authors: serrao a. Mediterr J Hematol Infect Dis. 2011;3(1):e2011021. doi: 10.4084/MJHID.2011.021. Epub 2011 May 16. Mediterr J Hematol Infect Dis. 2011. PMID: 21713076 Free PMC article.
Trisomy 8 in Philadelphia chromosome negative cell preceding the evolution of a Philadelphia chromosome positive clone with the same additional change during imatinib treatment: revisiting the role of genetic instability in chronic myeloid leukemia.
Cannella L, Loglisci G, Nanni M, De Cuia MR, Colafigli G, Salaroli A, Serrao A, Alimena G, Breccia M. Cannella L, et al. Among authors: serrao a. Leuk Lymphoma. 2012 Mar;53(3):497-8. doi: 10.3109/10428194.2011.615425. Epub 2011 Sep 29. Leuk Lymphoma. 2012. PMID: 21854086 No abstract available.
Application of French prognostic score to patients with International Prognostic Scoring System intermediate-2 or high risk myelodysplastic syndromes treated with 5-azacitidine is able to predict overall survival and rate of response.
Breccia M, Loglisci G, Cannella L, Finsinger P, Mancini M, Serrao A, Santopietro M, Salaroli A, Alimena G. Breccia M, et al. Among authors: serrao a. Leuk Lymphoma. 2012 May;53(5):985-6. doi: 10.3109/10428194.2011.643408. Epub 2012 Jan 11. Leuk Lymphoma. 2012. PMID: 22112007 No abstract available.
94 results